Meanwhile, GAS5 is also involved in the progression of many types of cancer, such as bladder cancer (BC) (Zhang et al., 2017), colorectal cancer (CRC) (Yin et al., 2014; Li et al., 2017), non-small cell lung cancer (NSCLC) (Shi et al., 2015; Wu et al., 2016), breast cancer (BRC) (Li W. et al., 2016), hepatocellular carcinoma (HCC) (Tu et al., 2014; Chang et al., 2016; Hu et al., 2016), epithelial ovarian cancer (EOC) (Gao et al., 2015), gastric cancer (GC) (Sun et al., 2014), cervical cancer (CEC) (Cao et al., 2014), and head and neck squamous cell carcinoma (HNSCC) (Gee et al., 2011). This evidence concerns the gene GAS5 and breast cancer.